Sign In
Buy CSBR
$5.69
-0.0350 (-0.611%)
At Close: Jun 03, 2026
Champions Oncology (NASDAQ:CSBR) Share Price Passes Below Two Hundred Day Moving Average – Time to Sell?
03:55am, Friday, 24'th Apr 2026
Champions Oncology, Inc. (NASDAQ: CSBR - Get Free Report) shares passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $6.48 and
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
01:40pm, Thursday, 09'th Apr 2026
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions HACKENSACK, NJ / ACCESS Newswire / April 9, 2026 / Champions
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
10:55am, Monday, 30'th Mar 2026
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology, Inc. (Nasd
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
05:42pm, Thursday, 12'th Mar 2026
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
Champions Oncology Reports Revenue of $16.6 Million
04:01pm, Thursday, 12'th Mar 2026
Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for the fiscal year HACKENSACK, NJ / ACCESS Newswire / March 12, 2026 / Champions Oncology, Inc. (Nasdaq:
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
04:00pm, Thursday, 05'th Mar 2026
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the th
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
06:09pm, Monday, 15'th Dec 2025
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
Market Today: Ford axes Lightning, iRobot bankrupt, Nvidia-China chips
05:36pm, Monday, 15'th Dec 2025
Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâelectric Fâ150 Lightning and replace it with a plugâin
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
04:00pm, Monday, 15'th Dec 2025
We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA for the fiscal year HACKENSACK, NJ / ACCESS Newswire / December 15, 2025 / Champions Oncology, Inc.
First Look: iRobot Bankruptcy, Netflix-WBD Fight, Tesla Robotaxi
07:38am, Monday, 15'th Dec 2025
Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by contract manufacturer Picea Robotics, saying operations and
Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
03:27am, Monday, 15'th Dec 2025
U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear and Greed index moved to Fear zone at 42.2.
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
04:00pm, Monday, 08'th Dec 2025
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the
Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript
06:35pm, Monday, 15'th Sep 2025
Champions Oncology, Inc. (NASDAQ:CSBR ) Q1 2026 Earnings Call September 15, 2025 4:30 PM EDT Company Participants Robert Brainin - CEO & Director David Miller - Chief Financial Officer Conference Call
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
04:50pm, Monday, 15'th Sep 2025
This release contains a headline correction from the previous publication. Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
04:30pm, Wednesday, 10'th Sep 2025
HACKENSACK, NJ / ACCESS Newswire / September 10, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions,
